- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,124GBP
- Report
- March 2024
- 145 Pages
Global
From €3746EUR$3,899USD£3,216GBP
- Report
- January 2024
- 395 Pages
Global
From €7206EUR$7,500USD£6,186GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,237GBP
- Report
- November 2023
- 381 Pages
Global
€4799EUR$4,995USD£4,120GBP
- Report
- August 2022
- 117 Pages
Global
From €4324EUR$4,500USD£3,712GBP
- Drug Pipelines
- July 2019
- 345 Pages
Global
€21139EUR$22,000USD£18,146GBP
- Drug Pipelines
- February 2022
- 60 Pages
Global
From €6721EUR$6,995USD£5,770GBP
- Report
- March 2024
- 90 Pages
Global
From €3500EUR$3,902USD£3,110GBP
- Report
- January 2021
- 145 Pages
China, Global
From €3000EUR$3,345USD£2,665GBP
- Report
- March 2022
Global
From €4660EUR$4,850USD£4,000GBP
- Report
- September 2021
Global
From €4660EUR$4,850USD£4,000GBP
- Report
- March 2021
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- February 2020
Japan, United States, ... Japan, United States, Europe
From €913EUR$950USD£784GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,186GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,186GBP
- Report
- September 2019
Global
From €5160EUR$5,370USD£4,429GBP
- Report
- January 2022
- 137 Pages
Global
From €4324EUR$4,500USD£3,712GBP
- Book
- July 2009
- 1116 Pages
Carbamazepine is a drug used to treat epilepsy and other neurological disorders. It is classified as an anticonvulsant and is used to treat seizures, trigeminal neuralgia, and bipolar disorder. It works by decreasing the activity of certain nerve cells in the brain, which helps to reduce the frequency and severity of seizures. It is also used to treat certain types of pain, such as trigeminal neuralgia. Carbamazepine is a member of the Central Nervous System (CNS) drug class, which includes drugs used to treat neurological disorders.
Carbamazepine is available in both generic and brand-name forms. It is available in tablet, capsule, and liquid forms, and is usually taken twice a day. The dosage and duration of treatment depend on the condition being treated. Common side effects of carbamazepine include dizziness, drowsiness, nausea, and vomiting.
Some companies in the Carbamazepine market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more